BDNF receptor blockade hinders the beneficial effects of exercise in a rat model of Parkinson's disease

Neuroscience

Volumn 237, Issue , 2013, Pages 118-129

  Real, C C ^a   Ferreira, A F B ^a   Chaves Kirsten, G P ^a   Torrao A S ^a   Pires, R S ^b   Britto, L R G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b MASTERS AND DOCTORAL PROGRAMS IN PHYSICAL THERAPY   (Brazil)

Author keywords

6 OHDA; BDNF; Intermittent treadmill exercise; K252a; Parkinson's disease; Tyrosine hydroxylase

Indexed keywords

APOMORPHINE; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; K 252A; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANATOMICAL VARIATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; ENZYME INHIBITION; HISTOLOGY; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PUTAMEN; RAT; RECEPTOR BLOCKING; SUBSTANTIA NIGRA PARS COMPACTA; TREADMILL EXERCISE;

ANALYSIS OF VARIANCE; ANIMALS; APOMORPHINE; CARBAZOLES; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; EXERCISE TEST; EXERCISE THERAPY; GENE EXPRESSION REGULATION; INDOLE ALKALOIDS; MALE; OXIDOPAMINE; PARKINSON DISEASE; PUTAMEN; RATS; RATS, WISTAR; RECEPTOR, TRKB; STEREOTYPED BEHAVIOR; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 84874763983     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.01.060     Document Type: Article

References (50)

1. Ahlskog J.E. Does vigorous exercise have a neuroprotective effect in Parkinson disease?. Neurology 2011, 77(3):288-294.
2. Al-Jarrah M., Jamous M., Al Zailaey K., Bweir S.O. Endurance exercise training promotes angiogenesis in the brain of chronic/progressive mouse model of Parkinson's disease. NeuroRehabilitation 2010, 26(4):369-373.
3. Alonso-Frech F., Sanahuja J.J., Rodriguez A.M. Exercise and physical therapy in early management of Parkinson disease. Neurologist 2011, (6 Suppl. 1):S47-S53.
4. Arida R.M., Scorza F.A., Gomes da Silva S., Cysneiros R.M., Cavalheiro E.A. Exercise paradigms to study brain injury recovery in rodents. Am J Phys Med Rehabil 2011, 90(6):452-465.
5. Baydyuk M., Nguyen M.T., Xu B. Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration. Exp Neurol 2011, 228(1):118-125.
6. Binder D.K., Scharfman H.E. Brain-derived neurotrophic factor. Growth Factors 2004, 22(3):123-131.
7. Blandini F., Armentero M.T., Martignoni E. The 6-hydroxydopamine model: news from the past. Parkinsonism Relat Disord 2008, 14:S124-S129.
8. Blum D., Torch S., Lambeng N., Nissou M., Benabid A.L., Sadoul R., Verna J.M. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 2001, 65:135-172.
9. Cadet P., Zhu W., Mantione K., Rymer M., Dardik I., Reisman S., Hagberg S., Stefano G.B. Cyclic exercise induces anti-inflammatory signal molecule increases in the plasma of Parkinson's patients. Int J Mol Med 2003, 12(4):485-492.
10. Chen H., Zhang S.M., Schwarzschild M.A., Hernán M.A., Ascherio A. Physical activity and the risk of Parkinson disease. Neurology 2005, 64:664-669.
11. Cohen A.D., Tillerson J.L., Smith A.D., Schallert T., Zigmond M.J. Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. J Neurochem 2003, 85:299-305.
12. Cotman C.W., Berchtold N.C. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci 2002, 25(6):295-301.
13. Devi S.A., Kiran T.R. Regional responses in antioxidant system to exercise training and dietary vitamin E in aging rat brain. Neurobiol Aging 2004, 25:501-508.
14. Dutta G., Zhang P., Liu B. The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery. Fundam Clin Pharmacol 2008, 22:453-464.
15. Fisher B.E., Wu A.D., Salem G.J., Song J., Lin C.H., Yip J., Cen S., Gordon J., Jakowec M., Petzinger G.M. The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson's disease. Arch Phys Med Rehabil 2008, 89:1221-1229.
16. Garcia P.C., Real C.C., Ferreira A.F., Alouche S.R., Britto L.R., Pires R.S. Different protocols of physical exercise produce different effects on synaptic and structural proteins in motor areas of the rat brain. Brain Res 2012, 1456:36-48.
17. Goodwin V.A., Richards S.H., Taylor R.S., Taylor A.H., Campbell J.L. The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and metaanalysis. Mov Disord 2008, 23(5):631-640.
18. Haavik J., Toska K. Tyrosine hydroxylase and Parkinson's disease. Mol Neurobiol 1998, 16(3):285-309.
19. Herman T., Giladi N., Gruendlinger L., Hausdorff J.M. Six weeks of intensive treadmill training improves gait and quality of life in patients with Parkinson's disease: a pilot study. Arch Phys Med Rehabil 2007, 88:1154-1158.
20. Hirsch M.A., Farley B.G. Exercise and neuroplasticity in persons living with Parkinson's disease. Eur J Phys Rehabil Med 2009, 45(2):215-229.
21. Holmes M.M., Galea L.A., Mistlberger R.E., Kempermann G. Adult hippocampal neurogenesis and voluntary running activity: circadian and dose dependent effects. J Neurosci Res 2004, 76:216-222.
22. Howells D.W., Porritt M.J., Wong J.Y., Batchelor P.E., Kalnins R., Hughes A.J., Donnan G.A. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra. Exp Neurol 2000, 166(1):127-135.
23. Jellinger K., Linert L., Kienzl E., Herlinger E., Youdim M.B. Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease. J Neural Transm Suppl 1995, 46:297-314.
24. Kafitz K.W., Rose C.R., Thoenen H., Konnerth A. Neurotrophin-evoked rapid excitation through TrkB receptors. Nature 1999, 401:918-921.
25. Kirik D., Rosenblad C., Björklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol 1998, 152(2):259-277.
26. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
27. Lau Y.S., Patki G., Das-Panja K., Le W.D., Ahmad S.O. Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson's disease with moderate neurodegeneration. Eur J Neurosci 2011, 33:1264-1274.
28. Lom B., Cohen-Cory S. Brain-derived neurotrophic factor differentially regulates retinal ganglion cell dendritic and axonal arborization in vivo. J Neurosci 1999, 19:9928-9938.
29. Mattson M.P., Gleichmann M., Cheng A. Mitochondria in neuroplasticity and neurological disorders. Neuron 2008, 60:748-766.
30. Mocchetti I., Bachis A., Nosheny R.L., Tanda G. Brain-derived neurotrophic factor expression in the substantia nigra does not change after lesions of dopaminergic neurons. Neurotox Res 2007, 12:135-143.
31. Nagahara A.H., Tuszynski M.H. Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat Rev Drug Discov 2011, 10(3):209-219.
32. Nguyen N., Lee S.B., Lee Y.S., Lee K.H., Ahn J.Y. Neuroprotection by NGF and BDNF against neurotoxin-exerted apoptotic death in neural stem cells are mediated through Trk receptors, activating PI3-kinase and MAPK pathways. Neurochem Res 2008, 34:942-951.
33. O'Dell S.J., Gross N.B., Fricks A.N., Casiano B.D., Nguyen T.B., Marshall J.F. Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection. Neuroscience 2007, 144:1141-1151.
34. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2005, Academic Press, San Diego. third ed.
35. Petzinger G.M., Walsh J.P., Akopian G., Hogg E., Abernathy A., Arevalo P., Turnquist P., Vucković M., Fisher B.E., Togasaki D.M., Jakowec M.W. Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. J Neurosci 2007, 27:5291-5300.
36. Real C.C., Ferreira A.F., Hernandes M.S., Britto L.R., Pires R.S. Exercise-induced plasticity of AMPA-type glutamate receptor subunits in the rat brain. Brain Res 2010, 1363:63-71.
37. Riddle D.R., Katz L.C., Lo D.C. Focal delivery of neurotrophins into the central nervous system using fluorescent latex microspheres. Biotechniques 1997, 23(928-934):936-937.
38. Salgado-Delgado R., Angeles-Castellanos M., Buijs M.R., Escobar C. Internal desynchronization in a model of night-work by forced activity in rats. Neuroscience 2008, 154:922-931.
39. Sasco A.J., Paffenbarger R.S., Gendre I., Wing A.L. The role of physical exercise in the occurrence of Parkinson's disease. Arch Neurol 1992, 49(4):360-365.
40. Schober A. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res 2004, 318:215-224.
41. Stahl K., Mylonakou M.N., Skare Ø., Amiry-Moghaddam M., Torp R. Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease. Brain Res 2011, 1378:105-118.
42. Steiner B., Winter C., Hosman K., Siebert E., Kempermann G., Petrus D.S., Kupsch A. Enriched environment induces cellular plasticity in the adult substantia nigra and improves motor behavior function in the 6-OHDA rat model of Parkinson's disease. Exp Neurol 2006, 199(2):291-300.
43. Sutoo D., Akiyama K. Regulation of brain function by exercise. Neurobiol Dis 2003, 13:1-14.
44. Tajiri N., Yasuhara T., Shingo T., Kondo A., Yuan W., Kadota T., Wang F., Baba T., Tayra J.T., Morimoto T., Jing M., Kikuchi Y., Kuramoto S., Agari T., Miyoshi Y., Fujino H., Obata F., Takeda I., Furuta T., Date I. Exercise exerts neuroprotective effects on Parkinson's disease model of rats. Brain Res 2010, 1310:200-207.
45. Tillerson J.L., Cohen A.D., Caudle W.M., Zigmond M.J., Schallert T., Miller G.W. Forced nonuse in unilateral parkinsonian rats exacerbates injury. J Neurosci 2002, 22:6790-6799.
46. Toole T., Hirsch M.A., Forkink A., Lehman D.A., Maitland C.G. The effects of a balance and strength training program on equilibrium in Parkinsonism: a preliminary study. NeuroRehabilitation 2000, 14:165-174.
47. Vaynman S., Ying Z., Gomez-Pinilla F. Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur J Neurosci 2004, 20:2580-2590.
48. Zigmond M.J., Cameron J.L., Leak R.K., Mirnics K., Russell V.A., Smeyne R.J., Smith A.D. Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency. Parkinsonism Relat Disord 2009, 15(S3):S42-S45.
49. Wu S.Y., Wang T.F., Yu L., Jen C.J., Chuang J.I., Wu F.S., Wu C.W., Kuo Y.M. Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway. Brain Behav Immun 2011, 25:135-146.
50. Yoon M.C., Shin M.S., Kim T.S., Kim B.K., Ko I.G., Sung Y.H., Kim S.E., Lee H.H., Kim Y.P., Kim C.J. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats. Neurosci Lett 2007, 423:12-17.